Effectiveness of Warnings Put Out by the Fda and Health Canada

Legal systems are not all about the top court.that is exactly what a pharmaceutical company
There can be many layers underneath wheremaking an antidepressant would want to hear.
cases and principles in dispute bubble up as theThe medication is supposed to change the mood
injured seek justice. One of the most contentiousof those who take zoloft for the better. But
of the current issues in the United States is themoods can swing both ways and, just as zoloft
idea of pre-emption. That state legislators shouldmay have its successes, so it may not help or
be allowed to shield the pharmaceuticalexaggerate depression.
manufacturers from liability even though theirWarning notices are, however, equally two-edged.
medications or medical devices may have injuredAlso published this month in the Canadian Medical
people. The justification is that the FederalAssociation Journal is research into the
Government has delegated the task of regulatingconsequences of the warning published by Health
the safety of medications and medical devices toCanada that there was an increased risk among
the Food and Drug Administration (FDA). Theyounger patients taking SSRIs including zoloft. In
courts therefore do not have the expertise orthe two years after the warning, there was a
the right to second-guess the Federal body.25% increase in the number of suicides in
So, here we comes McNellis v. Pfizer Inc. whichManitoba. Two further facts may be stated: there
was decided by the 3rd U.S. Circuit Court ofwas a significant reduction in the number of
Appeals in tandem with Colacicco v. Apotex Inc.younger patients brought forward for treatment,
The plaintiffs allege fault because theand a 14% drop in the number of prescriptions
manufacturers of zoloft and paxil failed to givewritten for patients under the age of eighteen
adequate warnings. Both are Selective Serotoninyears.
Reuptake Inhibitors (SSRIs) used to treatWhen potentially suicidal people go untreated,
depression. Patients taking either zoloft or paxilsome will commit suicide. Let us put the SSRIs
committed suicide. Although there is a black boxincluding zoloft to one side. Therapy and
notice that warns of the risk to some extent, thecounselling might have saved more lives. But the
FDA refused wording in a stronger and morewarning put out by Health Canada was vague. It
explicit form. The cases brought before the statedid not instruct doctors or their patients how to
courts of Pennsylvania and New Jersey reachedreact. Were they to stop prescribing or taking
opposite conclusions. On appeal, it was decidedzoloft? Were they to change the dosage of
that state laws do pre-empt the right to claimzoloft? What change in the symptoms after
that there was no adequate warning of the risktaking zoloft might indicate danger? When some
of suicide.parents are ashamed of their children's illness, it
Whether the FDA should or should not enforce acan be difficult to get them to bring their children
more strict labelling system has been the subjectfor treatment. Put out a vague warning with no
of debate for some years. The SSRIs includingspecific recommendation on how to react, and
zoloft are associated with changes in mood,prejudices are confirmed and the children are left
particularly among the young. Now, in one sense,untreated.